OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Thrombosis and Thrombolysis is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Post-thrombolytic coagulopathy and complications in patients with pulmonary embolism treated with fixed-dose systemic alteplase	48
Meta-analysis of restrictive versus liberal blood transfusion among patients with coronary artery disease	45
The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China	44
ICODE: the international COVID-19 thrombosis biomarkers colloquium—novel soluble biomarkers: circulating cell-free nucleic acids and other molecules	33
Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation	33
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement	32
Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity	28
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia	28
Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid	27
Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population	24
Endothelial progenitor cells overexpressing platelet derived growth factor-D facilitate deep vein thrombosis resolution	24
Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale	23
Incidence of thrombotic complications in COVID-19	22
Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population	22
The clot thickens—enhanced integration of stroke and thrombosis training	20
Conservative treatment vs thrombus removal for Iliofemoral vein thrombosis in patients with congenital abnormalities of the inferior vena cava: a case report and systematic review of the literature	20
Different patterns of white matter lesions among patent foramen ovale, atherosclerotic cerebral small vessel disease and cerebral venous thrombosis	20
Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma	19
Barriers and motivators to national board certification as a certified anticoagulation care provider	19